MiR‐5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|57|3|419-428

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.57, Iss.3, 2018-03, pp. : 419-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SLC34A2 regulates miR‐25‐Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell‐like cells

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 440-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

TGF‐β regulates the proliferation of lung adenocarcinoma cells by inhibiting PIK3R3 expression

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E162-E171

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eugenol potentiates cisplatin anti‐cancer activity through inhibition of ALDH‐positive breast cancer stem cells and the NF‐κB signaling pathway

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 333-346

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1442-1450

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐130b suppresses prostate cancer metastasis through down‐regulation of MMP2

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1292-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite